Skip to main content

Table 1 Therapeutic modalities to treat cardiac allograft vasculopathy

From: What is the optimal prophylaxis for treatment of cardiac allograft vasculopathy?

Antiproliferative agents:

Angiopeptin

Low-molecular weight heparin

Antimetabolites:

Methotrexate

Antithrombotic agents:

Hirulog

Antithrombin III

Monoclonal antibodies:

Growth factors

Adhesion molecules

Cytokines

Antihypertensive agents:

Calcium channel blockers

ACE inhibitors

New immunosuppressive agents

Use of photopheresis

Lipid-lowering agents:

HMG-CoA reductase inhibitors